My account
Injectables Orals Peptides Human Growth Hormone SARMs
Sign in
A
Anastrozole
B
Bacteriostatic water Boldenone undecylenate
C
Clenbuterol Clomiphene citrate Cabergoline
D
Drostanolone enanthate Drostanolone propionate Dehydroepiandrosterone (DHEA)
E
Erythropoietin Exemestane
F
Fluoxymesterone
H
Human chorionic gonadotropin Human growth hormone
L
Liothyronine sodium
M
Mecasermin Meldonium Mesterolone Methandienone Methenolone acetate Methenolone enanthate Melanotan-2
N
Nandrolone decanoate Nandrolone phenylpropionate
O
Oxandrolone Oxymetholone
S
Sildenafil citrate Stanozolol
T
Trenbolone enanthate Trestolone acetate Trenbolone acetate Testosterone undecanoate Testosterone propionate Testosterone base and suspension Tadalafil citrate Testosterone cypionate Testosterone enanthate Tamoxifen citrate Turinabol
Y
Yohimbine
Show 164 results
Manufacturers
Categories
Substances
Disagree
Home ZPHC ZPHC
Tirzepatide
Tirzepatide - ZPHC

Tirzepatide - ZPHC

Brand:
ZPHC
Category:
Peptides
Substance:
Tirzepatide
Package:
25 mg
Price:
0
See options
Product Overview

Approved in 2022, Tirzepatide (Mounjaro®) is a dual GIP/GLP-1 receptor agonist that brings a new dimension to Type 2 Diabetes (T2D) treatment. Unlike single-action GLP-1 therapies, it achieves dual benefits of glycemic control and weight loss. SURPASS-4 trial data showed it reduced mortality compared to insulin glargine, suggesting broader health impacts. Tirzepatide’s tolerability and minimal side effects make it a valuable option for managing T2D, while its combined metabolic effects may position it for future obesity studies and related conditions, marking a leap forward in diabetes care.

References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Tirzepatide by ZPHC, consult with your doctor or healthcare professional.

Explore More Products
Reviews
Leave Review
FAQ
What side effects does Tirzepatide have?
Side effects are similar to GLP-1RAs, mainly gastrointestinal issues like nausea, but it is generally well-tolerated.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.

How does Tirzepatide compare to insulin glargine?
In the SURPASS-4 trial, Tirzepatide had a lower mortality rate than insulin glargine in T2D patients.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.

Can Tirzepatide improve quality of life for T2D patients?
Yes, by improving blood sugar control and reducing weight, it supports better metabolic health.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.